Table 1.

Demographic Information and Treatment Items

Participant	Age	Education	Sex	Symptom Duration	Time Post-Diagnosis	Noun Proph	Noun Remed	Verb Proph	Verb Remed
LV1	75	20	M	62 months	12 months	X		X
LV2	74	12	F	29 months	5 months	X	X		X
LV3	70	18	F	74 months	3 months	X		X
LV4	57	13	F	68 months	4 months	X	X	X	X
LV5	67	18	F	40 months	3 months	X		X
LV6	70	12	F	43 months	2 months	X		X
LV7	73	16	M	13 months	1 month	X	X	X
LV8	76	18	F	76 months	4 months	X		X
LV9	75	18	F	45 months	4 months	X		X
LV10	75	16	M	33 months	5 months	X	X	X	X
LV11	77	17	F	48 months	30 months	X	X	X
SV1	76	16	F	20 months	8 months	X	X	X	X
SV2	67	18	F	112 months	2 months	X	X	X	X
SV3	55	16	F	19 months	1 month	X	X	X	X
SV4	69	20	F	23 months	5 months	X	X		X
SV5	70	16	F	40 months	4 months	X	X	X
NFV1	79	18	F	57 months	9 months	X		X
NFV2	76	16	F	28 months	4 months	X		X
NFV3	68	18	F	38 months	23 months	X		X
NFV4	74	12	M	34 months	4 months	X		X
NFV5	63	20	F	100 months	13 months	X
NFV6	66	16	F	43 months	6 months	X		X
NFV7	67	20	M	16 months	3 months	X		X
UPPA1	78	16	M	74 months	2 months	X	X	X	X
UPPA2	71	18	M	99 months	40 months		X		X
UPPA3	55	16	F	92 months	2 months	X		X	X
UPPA4	62	15	F	41 months	5 months	X	X		X
UPPA5	74	20	F	16 months	4 months	X	X		X
UPPA6	76	16	F	29 months	5 months	X	X		X
UPPA7	80	16	F	35 months	11 months	X		X
UPPA8	72	19	M	35 months	5 months	X		X
UPPA9	62	16	F	50 months	40 months		X		X
UPPA10	75	18	M	50 months	2 months	X		X
AD1	86	16	M	52 months	2 months	X		X
AD2	62	16	M	86 months	8 months	X		X
AD3	58	18	M	96 months	91 months		X		X
AD4	82	14	F	26 months	2 months	X		X

Note. LV: logopenic variant; SV: semantic variant; NFV: nonfluent/agrammatic variant; UPPA: unclassifiable primary progressive aphasia; AD: Alzheimer’s disease; Proph: Prophylaxis items; Remed: Remediation items.